Use of Xiaflex for Peyronie’s disease.
Injectable collagenase is the first treatment for Peyronie’s disease that demonstrated objective effectiveness in improving penile curvature compared to placebo treatment in a randomized controlled study. No other treatment for Peyronie’s disease in current use has been objectively shown to be as effective. Xiaflex was FDA approved for treatment of Peyronies disease in December of 2013.
How is Xiaflex for Peyronie’s disease treatment administered?
Xiaflex is administered intra-lesionally, meaning it is injected into the Peyronie’s plaque. Penile remodeling or modeling has also been used in addition to collagenase injections to achieve improvement in outcomes.
Read about the cost of Xiaflex/Collagenase injections.
Read about the benefits of Xiaflex/Collagenase.